Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973036 · ClinicalTrials.gov registry record · NA
FOLCROM Trial: Foley Catheter in Rupture of Membranes
A NA study of Premature Rupture of Membranes, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 5
- Study locations
NCT01973036 is a NA study of Premature Rupture of Membranes that has completed, run by Geisinger Clinic. The registered enrollment target is 201 participants. The trial reports 5 study locations across 3 states.
The verdict
NCT01973036, a NA study of Premature Rupture of Membranes, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 5
- Study locations
Study Summary
Multicenter randomized clinical trial comparing oxytocin versus oxytocin and foley catheter for induction in women who present with premature rupture of membranes who are not in labor.
Conditions Studied
Interventions
- DRUG Oxytocin
- DEVICE Foley Catheter
Study Locations (5)
Pennsylvania
- Lehigh Valley Hospital - Allentown
- Geisinger Medical Center - Danville
- Geisinger Wyoming Valley - Wilkes-Barre
Arizona
- Banner Good Samaritan Regional Medical Center - Phoenix
Delaware
- Christiana Care Health System CCHS - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01973036
The ClinicalTrials.gov registry entry for NCT01973036 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Premature Rupture of Membranes appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin is the first listed.
NCT01973036 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Arizona, Delaware.
Frequently Asked Questions
What is clinical trial NCT01973036 about?
NCT01973036 is a clinical study titled "FOLCROM Trial: Foley Catheter in Rupture of Membranes". Multicenter randomized clinical trial comparing oxytocin versus oxytocin and foley catheter for induction in women who present with premature rupture of membranes who are not in labor.
What is the current status of trial NCT01973036?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2014-03. Estimated completion is 2016-08.
What conditions does trial NCT01973036 study?
This clinical trial studies the following conditions: Premature Rupture of Membranes.
What interventions are being tested in trial NCT01973036?
The interventions under investigation include: Oxytocin (DRUG), Foley Catheter (DEVICE).
Who is sponsoring clinical trial NCT01973036?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01973036 being conducted?
This trial has 5 study locations across Arizona, Delaware, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.